Media Center
- No
-
Category
- Show all
- Press Release
- News Article
- PR Video
- CEO Story
- Title
- Author
- Time uploaded
- Views
- Likes
- 140
- Press Release
- Press Release PharmAbcine Announces Joint Patent Application with MSD for the Treatment of Cancer
- PharmAbcine
- 10 Sep 2021
- Views1612
- 0
- 139
- Press Release
- Press Release PharmAbcine receives the ‘Best Poster Award’ for its additional nonclinical data presentation of PMC-309 at KSMO 2021
- PharmAbcine
- 6 Sep 2021
- Views2670
- 0
- 138
- Press Release
- Press Release PharmAbcine Receives HREC Clearance for Phase II Trial of Olinvacimab and Pembrolizumab in mTNBC
- PharmAbcine
- 6 Sep 2021
- Views1507
- 0
- 137
- CEO Story
- CEO Story H.C. Wainwright Investment Conference
- PharmAbcine
- 23 Aug 2021
- Views1394
- 0
- 136
- Press Release
- Press Release PharmAbcine to Participate in H.C. Wainright 23rd Annual Global Investment Conference
- PharmAbcine
- 23 Aug 2021
- Views1216
- 0
- 135
- Press Release
- Press Release PharmAbcine Announces Submission of PCT for an Anti-ANG2 Antibody for the Treatment of Ocular Diseases
- PharmAbcine
- 20 Aug 2021
- Views1451
- 0
- 134
- Press Release
- Press Release PharmAbcine to Participate in Biotechgate Digital Partnering
- PharmAbcine
- 18 Aug 2021
- Views1349
- 0
- 133
- CEO Story
- CEO Story H.C Wainright Ophthalmology Virtual Conference
- PharmAbcine
- 27 Jul 2021
- Views1461
- 0
- 132
- Press Release
- Press Release PharmAbcine to Present at H.C Wainwright Ophthalmology Virtual Conference
- PharmAbcine
- 27 Jul 2021
- Views1591
- 0
- 131
- PR Video
- PR Video PharmAbcine, a clinical stage immune-oncology company, delivered a presentation at BIO DIGITAL 2021, June 10-11 & 14-18, 2021.
- PharmAbcine
- 19 Jul 2021
- Views1451
- 0